SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-24-087277
Filing Date
2024-08-08
Accepted
2024-08-08 16:15:42
Documents
16
Effectiveness Date
2024-08-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2421099d1_s8.htm S-8 65403
2 EXHIBIT 5.1 tm2421099d1_ex5-1.htm EX-5.1 6371
3 EXHIBIT 23.2 tm2421099d1_ex23-2.htm EX-23.2 2351
4 FILING FEE IXBRL tm2421099d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16418
5 GRAPHIC tm2421099d1_ex5-1img001.jpg GRAPHIC 2397
  Complete submission text file 0001104659-24-087277.txt   228561

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2421099d1_ex-filingfees_htm.xml XML 6738
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-281376 | Film No.: 241188577
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)